Akari Therapeutics PLC (AKTX)

1.60 +0.12 (+8.11%) USD  |  NASDAQ  |  May 20, 16:00
1.60 0.00 (0.00%) After-Hours: 18:38
More

Akari Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2020. Upgrade now.
Date Value
December 05, 2022 --
April 23, 2021 --
September 04, 2020 --
Date Value
June 01, 2020 --
April 02, 2020 --
March 13, 2020 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

--
Minimum
Apr 23 2021
Upgrade
Maximum
Mar 13 2020
Upgrade
Average
Upgrade
Median
Mar 13 2020

Revenue Estimates for Next Fiscal Year Benchmarks

DBV Technologies SA Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals Plc Upgrade
NuCana PLC Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade